5mg Tofacitinib Tab
Jun 09, 2023
Tofacitinib Tab (5mg)
TACOTINIB is a medication that is available in tablet form. It belongs to a class of drugs called Janus kinase (JAK) inhibitors. TACOTINIB is primarily used to treat certain inflammatory conditions, particularly rheumatoid arthritis.
TACOTINIB is approved for the treatment of rheumatoid arthritis (RA) in adults who have had an inadequate response to or cannot tolerate other disease-modifying antirheumatic drugs (DMARDs).
TACOTINIB works by inhibiting Janus kinases, which are enzymes involved in the signaling pathways of certain immune cells. By blocking these enzymes, TACOTINIB helps to reduce the inflammation associated with RA.
TACOTINIB is available in strengths of 5 and 11mg.
STERIS PHARMA Generic medicines are cost-effective options for insurance companies, public healthcare systems, and individuals. Generic medicines are usually more affordable than their brand-name counterparts. Generic medicines undergo a rigorous regulatory process to ensure they meet the same quality and safety standards as brand-name drugs.
For further information please contact:
contact@sterispharma.com
order now: https://www.sterisonline.com/product/tacotinib-5-133969
Recent Post
What Are Metformin HCl PR 850 mg & Glimepiride 3 mg Tablets?
What Is Keratin Biotin Conditioner? Everything You Need to Know
What Are Tablets of Thiamine Nitrate, Pyridoxine Hydrochloride, Folic Acid and Minerals? A Complete Guide
What Is Montelukast + Levocetirizine Syrup? A Complete Guide
How Dapagliflozin, Teneligliptin & Metformin 1000 ER Work Together for Your Heart and Sugar
The Science of BUDESHINE: How Budesonide Aqueous Spray Works for You
Best Anti-Dandruff Shampoo with Luliconazole, Salicylic Acid & Zinc Pyrithione in 2026
Managing Diabetic Neuropathy: Why Pregabalin, Methylcobalamin & Duloxetine is the Best Trio
Powerful Triple Action Cough Syrup: Terbutaline + Ambroxol + Guaiphenesin for Better Breathing
Dapagliflozin 10mg Glimepiride 2mg Metformin 500mg ER Tablets: Best Triple Therapy for Type 2 Diabetes in 2026